Literature DB >> 32205532

Definition, Biology, and History of Oligometastatic and Oligoprogressive Disease.

Corey C Foster1, Sean P Pitroda, Ralph R Weichselbaum.   

Abstract

Historical theories of metastasis have been informed by the seed and soil hypothesis, the Halsteadian paradigm proposing an orderly spread from local to distant sites, and the presumption that cancer is an inherently systemic process even in the earliest cases. The more contemporary spectrum theory now suggests that the propensity for distant spread exists along a continuum of metastatic virulence. Tumors with limited metastatic potential represent one subset along this spectrum that could potentially be cured with local ablative therapy. Integrating clinical and molecular features to biologically inform the classification of not only oligometastatic or oligoprogressive disease but also the entire metastatic spectrum holds great promise to improve prognostication and inform clinical decision making. To this end, the inclusion of molecular correlative studies and biospecimen collection on prospective protocols is imperative.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32205532     DOI: 10.1097/PPO.0000000000000434

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  6 in total

Review 1.  The future of PSMA PET and WB MRI as next-generation imaging tools in prostate cancer.

Authors:  Yishen Wang; Joao R Galante; Athar Haroon; Simon Wan; Asim Afaq; Heather Payne; Jamshed Bomanji; Sola Adeleke; Veeru Kasivisvanathan
Journal:  Nat Rev Urol       Date:  2022-07-04       Impact factor: 16.430

2.  MYC Levels Regulate Metastatic Heterogeneity in Pancreatic Adenocarcinoma.

Authors:  Ravikanth Maddipati; Robert J Norgard; Timour Baslan; Komal S Rathi; Amy Zhang; Asal Saeid; Taku Higashihara; Feng Wu; Angad Kumar; Valli Annamalai; Saurav Bhattacharya; Pichai Raman; Christian A Adkisson; Jason R Pitarresi; Maximilian D Wengyn; Taiji Yamazoe; Jinyang Li; David Balli; Michael J LaRiviere; Tuong-Vi C Ngo; Ian W Folkert; Ian D Millstein; Jonathan Bermeo; Erica L Carpenter; John C McAuliffe; Maja H Oktay; Rolf A Brekken; Scott W Lowe; Christine A Iacobuzio-Donahue; Faiyaz Notta; Ben Z Stanger
Journal:  Cancer Discov       Date:  2021-09-22       Impact factor: 38.272

Review 3.  The role of the surgeon in the management of oligometastatic non-small cell lung cancer: a literature review.

Authors:  Lawek Berzenji; Sophie Debaenst; Jeroen M H Hendriks; Suresh Krishan Yogeswaran; Patrick Lauwers; Paul E Van Schil
Journal:  Transl Lung Cancer Res       Date:  2021-07

Review 4.  Narrative review: molecular and genetic profiling of oligometastatic non-small cell lung cancer.

Authors:  Sawsan Rashdan; Puneeth Iyengar; John D Minna; David E Gerber
Journal:  Transl Lung Cancer Res       Date:  2021-07

5.  Radiosensitivity of Breast Cancer Cells Is Dependent on the Organ Microenvironment.

Authors:  Genyan Guo; Ryan T Morse; Jie Wang; Xuan Chen; Jiajie Zhang; Andrew Z Wang
Journal:  Front Oncol       Date:  2022-05-12       Impact factor: 5.738

Review 6.  Development of the Breast Surgical Oncology Fellowship in the United States.

Authors:  Lauren Zammerilla Westcott; Ronald C Jones; James W Fleshman
Journal:  Breast J       Date:  2022-05-19       Impact factor: 2.269

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.